ArticleThe journal of allergy and clinical immunology. Global2025
School-based asthma therapy: Improving medication adherence, asthma control, and health care utilization.
Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stock Inhalers in Chicago Public Schools: Using the RE-AIM Framework to Assess Impact.Pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Undertreatment and poor adherence remain prevalent for children with persistent asthma. School-based asthma therapy (SBAT) provides guideline-based treatment by systematic school-based asthma screenings and direct administration of daily controller medications. Objective: We examined asthma control and health care utilization for children enrolled in the SBAT program in Columbus, Ohio, from 2013 to 2019. Methods: Six-year retrospective medical records were reviewed for 1 year before and 1 year after SBAT enrollment for children aged 5 to 19 years from 2 metropolitan school districts. Asthma control was assessed by the Asthma Control Test (ACT) and health care provider (HCP) ratings. Information was collected regarding asthma-related health care utilization, including emergency department (ED), urgent care, and acute care visits; hospitalizations; and pediatric intensive care unit (PICU) admissions. Results: Percentage increases in well-controlled asthma were 37% (ACT) and 56% (HCP). Asthma-related ED visits decreased by 49%, hospitalizations 50%, PICU admissions 71%, urgent care visits 41%, and acute care visits 38%. Black and Latino children had significant improvements. Black children saw 40% (ACT) and 66% (HCP) increases in well-controlled asthma, with reductions of 42% in ED and urgent care visits, 52% in acute care visits, and 49% and 67% declines in hospitalizations and PICU admissions, respectively. Latino children had 55% (ACT) and 33% (HCP) asthma control improvements, with 62%, 81%, and 50% drops in ED, urgent care, and acute care visits, respectively; hospitalizations decreased by 40% and PICU admissions by 100%. Conclusions: The SBAT program would serve well as a model for enhancing controller medication adherence, reducing morbidity, and bridging the health disparities gap for children with poorly controlled asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.